Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Tumori
|
August 31, 1993
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer
F Perrone, S De Placido, C Carlomagno, et al.
Clinical and Experimental Immunology
|
June 1, 1992
Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy
E Mariani, A Facchini, M C Honorati, et al.
Tumori
|
January 1, 1995
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province
S de Placido, F Nuzzo, F Perrone, et al.
Revista De Saude Publica
|
February 25, 1999
[Determination of HIV protein 24 in feces of Triatoma infestans fed with blood from AIDS patients]
S F Nuzzo, V Amato Neto, L M Braz, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2013
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer
G Bisagni, A Musolino, M Panebianco, et al.
British Journal of Cancer
|
April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
C Pacilio, A Morabito, F Nuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F Perrone, C Jommi, M Di Maio, et al.
ESMO Open
|
March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
L Arenare, R Di Liello, P De Placido, et al.
ESMO Open
|
December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]
L Arenare, R Di Liello, P De Placido, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 12, 2002
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse
M Tampellini, A Berruti, G Gorzegno, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Tumori
|
August 31, 1993
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer
F Perrone, S De Placido, C Carlomagno, et al.
Clinical and Experimental Immunology
|
June 1, 1992
Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy
E Mariani, A Facchini, M C Honorati, et al.
Tumori
|
January 1, 1995
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province
S de Placido, F Nuzzo, F Perrone, et al.
Revista De Saude Publica
|
February 25, 1999
[Determination of HIV protein 24 in feces of Triatoma infestans fed with blood from AIDS patients]
S F Nuzzo, V Amato Neto, L M Braz, et al.
Cancer Chemotherapy and Pharmacology
|
February 5, 2013
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer
G Bisagni, A Musolino, M Panebianco, et al.
British Journal of Cancer
|
April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
C Pacilio, A Morabito, F Nuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F Perrone, C Jommi, M Di Maio, et al.
ESMO Open
|
March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
L Arenare, R Di Liello, P De Placido, et al.
ESMO Open
|
December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]
L Arenare, R Di Liello, P De Placido, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 12, 2002
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse
M Tampellini, A Berruti, G Gorzegno, et al.
Page
of 8